mGain - sEMG-based Gamified Therapy for Improved Upper Limb Rehabilitation
NCT ID: NCT06023316
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2023-08-08
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All participants will undertake four weeks of therapy. Conducting therapy five days a week for 30 minutes a day. In addition, participants will have an initial and final assessment visit at a study site, with each visit expected to last 1-2 hours.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myoelectric Game Training and Outcomes
NCT04354493
Studying Electromyographic Activity in Patients With Upper Limb Amputations
NCT02956603
FAME: Functional Assessment of a Myoelectric Orthosis Hand Orthoses
NCT04266158
Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain
NCT02281539
Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis
NCT02974465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Initial Assessment: Eligible individuals will complete a baseline assessment including range of motion, manual muscle testing, and handheld dynamometry of the target limb(s). Target muscles for therapy will be identified (e.g., biceps, triceps, deltoids, forearm flexors, forearm extensors) and a trial of sEMG evaluation to detect muscle signal will be conducted. If detectable muscle signal is present, participants will complete the consent process and be enrolled in the study. Each participant will be taught the use of the mGain system using their own mobile phone or tablet and be given a therapeutic regimen to target their individual muscle weakness. Participants will then be asked to demonstrate use of the system. Participants can ask questions to ensure they understand system usage and the expectations when at home. Participants will complete baseline validated outcome measures such as the QuickDASH (Disabilities of the Arm, Shoulder and Hand questionnaire) and PROMIS Self-Efficacy Scale.
Home Therapy: For the four weeks following the initial assessment, participants will be asked to conduct a minimum of 30 minutes of therapy per day, 5 days a week, at home using the mGain system targeting the muscles identified during the initial assessment. Individuals will be asked to complete short questionnaires and write in an eDiary about their experience after conducting their daily exercises. A member of the study team will contact the participants on a weekly basis to provide technical support, inquire about adherence, and encourage participation. Data for each participant will be uploaded to Orthocare Innovations' HIPAA compliant cloud-based server.
Final Assessment: Participants will complete a final assessment of strength, range of motion, and manual muscle testing. Additionally, participants will complete outcome measures and surveys such as the QuickDASH, PROMIS Self-Efficacy, system usability scale, and a custom feasibility survey.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mGain system
mGain system: passive, noninvasive, Bluetooth-enabled, wire-free, surface electromyography measurement device that provides input to a mobile app for an interactive gaming platform
mGain system
passive, noninvasive surface electromyography measurement device and gaming mobile application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mGain system
passive, noninvasive surface electromyography measurement device and gaming mobile application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Upper limb weakness due to central or peripheral neurologic injury, stroke, or nerve reconstruction or tendon transfer surgery within one year; or upper limb amputation (e.g., transradial or transhumeral)
* Muscle strength of three or less on the Medical Research Council Manual Muscle Testing grading scale in any of the following (as appropriate for individuals with intact limbs): shoulder abduction, elbow flexion, elbow extension, wrist extension, wrist flexion, or finger extension
* Access to and willingness to use smart phone or tablet
* Able to tolerate participation in activity for at least 30 minutes of therapy exercises per day for five days per week
* Able to provide written informed consent for study participation
Exclusion Criteria
* Pregnancy
* History of prior central or peripheral neurologic injury or neuromuscular condition
* No muscle activation detectable by the mGain sEMG sensor
* Progressive neurologic deficit
* Impaired dexterity on the contralateral side such that participant is unable to use the device
* Spasticity with modified Ashworth score of three or greater
* Severe joint contracture (\>50% of available range)
* Sensitive skin that would not tolerate wearing the mGain sEMG sensor
* Medical instability
* Confounding injury, musculoskeletal issues, or cognitive issues that limit effective participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Disability, Independent Living, and Rehabilitation Research
FED
Orthocare Innovations, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Boone, PhD
Role: PRINCIPAL_INVESTIGATOR
Orthocare Innovations, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthocare Innovations, LLC
Edmonds, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mGain-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.